Universality Does Not Mean Access: A response to CHPI’s “Who needs pharmacare?”

As the debate about pharmacare in Canada heats up with the Implementation of the Advisory Council on Pharmacare, and the role this plays in the coming federal election in 2019, various pieces that misrepresent the case for pharmacare are appearing.

While consumers and healthcare advocates need to gain knowledge about the issues surrounding pharmacare, they also need to be cautious of inaccurate titles and claims, especially in cases where words like “studies and statistics” are used to give a sense of validity.

Recently, the Canadian Health Policy Institute (CHPI) released a report on a paper called “Prescription drug plan coverage 2016: how many Canadians were insured, under-insured or uninsured?”

Read CCSN’s response here.